Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Anna Cecilie Lefèvre, Jan Alsner, Brita Singers Sørensen, Trine Tramm, Kasper Toustrup, Jens Overgaard & Karen-Lise Garm Spindler. (2022) Hypoxia and local tumour control in squamous cell carcinoma of the anus – a hypothesis-generating study. Acta Oncologica 61:9, pages 1132-1135.
Read now
Read now
Jan Alsner, Jens Overgaard, Trine Tramm & Jacob Christian Lindegaard. (2022) Hypoxic gene expression is a prognostic factor for disease free survival in a cohort of locally advanced squamous cell cancer of the uterine cervix. Acta Oncologica 61:2, pages 172-178.
Read now
Read now
Jacob Kinggaard Lilja-Fischer, Benedicte Parm Ulhøi, Jan Alsner, Magnus Stougaard, Mette Skovhus Thomsen, Morten Busk, Pernille Lassen, Torben Steiniche, Viveque Egsgaard Nielsen & Jens Overgaard. (2019) Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts. Acta Oncologica 58:10, pages 1489-1494.
Read now
Read now
Morten Busk, Michael R. Horsman, Jens Overgaard & Steen Jakobsen. (2019) Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumes. Acta Oncologica 58:10, pages 1476-1482.
Read now
Read now
M. Bogowicz, S. Tanadini-Lang, P. Veit-Haibach, M. Pruschy, S. Bender, A. Sharma, M. Hüllner, G. Studer, S. Stieb, H. Hemmatazad, S. Glatz, M. Guckenberger & O. Riesterer. (2019) Perfusion CT radiomics as potential prognostic biomarker in head and neck squamous cell carcinoma. Acta Oncologica 58:10, pages 1514-1518.
Read now
Read now
Cai Grau, Morten Høyer, Per Rugaard Poulsen, Ludvig Paul Muren, Stine Sofia Korreman, Kari Tanderup, Jacob Christian Lindegaard, Jan Alsner & Jens Overgaard. (2017) Rethink radiotherapy – BIGART 2017. Acta Oncologica 56:11, pages 1341-1352.
Read now
Read now
Marta Bogowicz, Oliver Riesterer, Luisa Sabrina Stark, Gabriela Studer, Jan Unkelbach, Matthias Guckenberger & Stephanie Tanadini-Lang. (2017) Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma. Acta Oncologica 56:11, pages 1531-1536.
Read now
Read now
Articles from other publishers (42)
Raefa Abou Khouzam, Bassam Janji, Jerome Thiery, Rania Faouzi Zaarour, Ali N. Chamseddine, Hemma Mayr, Pierre Savagner, Claudine Kieda, Sophie Gad, Stéphanie Buart, Jean–Marie Lehn, Perparim Limani & Salem Chouaib. (2023) Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy. Seminars in Cancer Biology 97, pages 104-123.
Crossref
Crossref
Bouchra Tawk, Katrin Rein, Christian Schwager, Maximilian Knoll, Ute Wirkner, Juliane Hörner-Rieber, Jakob Liermann, Ina Kurth, Panagiotis Balermpas, Claus Rödel, Annett Linge, Steffen Löck, Fabian Lohaus, Ingeborg Tinhofer, Mechtild Krause, Martin Stuschke, Anca Ligia Grosu, Daniel Zips, Stephanie E. Combs, Claus Belka, Albrecht Stenzinger, Christel Herold-Mende, Michael Baumann, Peter Schirmacher, Jürgen Debus & Amir Abdollahi. (2023) DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy. Clinical Cancer Research 29:16, pages 3051-3064.
Crossref
Crossref
Diogo Alpuim Costa, Mafalda Sampaio-Alves, Eduardo Netto, Gonçalo Fernandez, Edson Oliveira, Andreia Teixeira, Pedro Modas Daniel, Guilherme Silva Bernardo & Carla Amaro. (2022) Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma—A Scoping Review. Frontiers in Neurology 13.
Crossref
Crossref
Steffen Löck, Annett Linge, Fabian Lohaus, Nadja Ebert, Volker Gudziol, Alexander Nowak, Ingeborg Tinhofer, Goda Kalinauskaite, Maja Guberina, Martin Stuschke, Panagiotis Balermpas, Jens von der Grün, Anca-Ligia Grosu, Jürgen Debus, Ute Ganswindt, Claus Belka, Jan C. Peeken, Stephanie E. Combs, Chiara De-Colle, Daniel Zips, Gustavo B. Baretton, Mechthild Krause & Michael Baumann. (2022) Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC – Hypothesis generation on a multicentre cohort of the DKTK-ROG. Radiotherapy and Oncology 169, pages 8-14.
Crossref
Crossref
Alexander Rühle, Nicole Wiedenmann, Jamina T. Fennell, Michael Mix, Juri Ruf, Raluca Stoian, Andreas R. Thomsen, Peter Vaupel, Dimos Baltas, Anca-L. Grosu & Nils H. Nicolay. (2021) Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial. European Journal of Nuclear Medicine and Molecular Imaging 49:5, pages 1650-1660.
Crossref
Crossref
Alexander Rühle, Anca-L. Grosu, Nicole Wiedenmann, Juri Ruf, Birgit Bieber, Raluca Stoian, Andreas R. Thomsen, Eleni Gkika, Peter Vaupel, Dimos Baltas, Wolfgang A. Weber, Michael Mix & Nils H. Nicolay. (2022) The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation. Clinical and Translational Radiation Oncology 33, pages 120-127.
Crossref
Crossref
Eric S. Diffenderfer, Brita S. Sørensen, Alejandro Mazal & David J. Carlson. (2021) The current status of preclinical proton FLASH radiation and future directions. Medical Physics 49:3, pages 2039-2054.
Crossref
Crossref
Valentin Van den bossche, Hannah Zaryouh, Marianela Vara-Messler, Julie Vignau, Jean-Pascal Machiels, An Wouters, Sandra Schmitz & Cyril Corbet. (2022) Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Drug Resistance Updates 60, pages 100806.
Crossref
Crossref
Bhanu P. Venkatesulu, Prashanth Girdhar, Henry S. Park, William M. Mendenhall & Vivek Verma. 2022. Multidisciplinary Management of Head and Neck Cancer. Multidisciplinary Management of Head and Neck Cancer
45
59
.
M.R. Horsman, B.S. Sørensen, M. Busk & D.W. Siemann. (2021) Therapeutic Modification of Hypoxia. Clinical Oncology 33:11, pages e492-e509.
Crossref
Crossref
Alexander Rühle, Anca-L. Grosu, Nicole Wiedenmann, Raluca Stoian, Erik Haehl, Constantinos Zamboglou, Dimos Baltas, Martin Werner, Gian Kayser & Nils H. Nicolay. (2021) Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation – Post-hoc analysis from a prospective imaging trial. Radiotherapy and Oncology 159, pages 75-81.
Crossref
Crossref
Niluja Thiruthaneeswaran, Becky A.S. Bibby, Lingjang Yang, Peter J. Hoskin, Robert G. Bristow, Ananya Choudhury & Catharine West. (2021) Lost in application: Measuring hypoxia for radiotherapy optimisation. European Journal of Cancer 148, pages 260-276.
Crossref
Crossref
Raefa Abou Khouzam, Klaudia Brodaczewska, Aleksandra Filipiak, Nagwa Ahmed Zeinelabdin, Stephanie Buart, Cezary Szczylik, Claudine Kieda & Salem Chouaib. (2021) Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies. Frontiers in Immunology 11.
Crossref
Crossref
Ingrid Masson, Marie Dutreix & Stéphane Supiot. (2021) Innovation en radiothérapie en 2021. Bulletin du Cancer 108:1, pages 42-49.
Crossref
Crossref
Mara S. Serafini, Laura Lopez-Perez, Giuseppe Fico, Lisa Licitra, Loris De Cecco & Carlo Resteghini. (2020) Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures. Cancers of the Head & Neck 5:1.
Crossref
Crossref
Mark Gray, James Meehan, Arran K. Turnbull, Carlos Martínez-Pérez, Charlene Kay, Lisa Y. Pang & David J. Argyle. (2020) The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology. Frontiers in Veterinary Science 7.
Crossref
Crossref
Morten Busk, Jens Overgaard & Michael R. Horsman. (2020) Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions. Seminars in Nuclear Medicine 50:6, pages 562-583.
Crossref
Crossref
Evelien Schaafsma, Yanding Zhao, Yue Wang, Frederick S. Varn, Kenneth Zhu, Huan Yang & Chao Cheng. (2020) Whole transcriptome signature for prognostic prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer. Laboratory Investigation 100:10, pages 1356-1366.
Crossref
Crossref
Raefa Abou Khouzam, Hassan Venkatesh Goutham, Rania Faouzi Zaarour, Ali N Chamseddine, Amirtharaj Francis, Stéphanie Buart, Stéphane Terry & Salem Chouaib. (2020) Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy. Seminars in Cancer Biology 65, pages 140-154.
Crossref
Crossref
Katheryn Begg & Mahvash Tavassoli. (2020) Inside the hypoxic tumour: reprogramming of the DDR and radioresistance. Cell Death Discovery 6:1.
Crossref
Crossref
Christina S. Fjeldbo, Tord Hompland, Tiril Hillestad, Eva-Katrine Aarnes, Clara-Cecilie Günther, Gunnar B. Kristensen, Eirik Malinen & Heidi Lyng. (2020) Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity. EBioMedicine 57, pages 102841.
Crossref
Crossref
Martijn van der Heijden, Paul B.M. Essers, Caroline V.M. Verhagen, Stefan M. Willems, Joyce Sanders, Reinout H. de Roest, David M. Vossen, C. René Leemans, Marcel Verheij, Ruud H. Brakenhoff, Michiel W.M. van den Brekel & Conchita Vens. (2020) Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. Radiotherapy and Oncology 147, pages 186-194.
Crossref
Crossref
Stefan Schmidt, Annett Linge, Marianne Grosser, Fabian Lohaus, Volker Gudziol, Alexander Nowak, Ingeborg Tinhofer, Volker Budach, Ali Sak, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Henning Schäfer, Anca-Ligia Grosu, Amir Abdollahi, Jürgen Debus, Ute Ganswindt, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, David Mönnich, Daniel Zips, Gustavo B. Baretton, Frank Buchholz, Michael Baumann, Mechthild Krause & Steffen Löck. (2020) Comparison of GeneChip, nCounter, and Real-Time PCR–Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. The Journal of Molecular Diagnostics 22:6, pages 801-810.
Crossref
Crossref
Sarah Deschuymer, Brita Singers Sørensen, Rüveyda Dok, Annouschka Laenen, Esther Hauben, Jens Overgaard & Sandra Nuyts. (2020) Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy. Strahlentherapie und Onkologie 196:6, pages 552-560.
Crossref
Crossref
James Meehan, Mark Gray, Carlos Martínez-Pérez, Charlene Kay, Lisa Y. Pang, Jennifer A. Fraser, Amy V. Poole, Ian H. Kunkler, Simon P. Langdon, David Argyle & Arran K. Turnbull. (2020) Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Brita Singers Sørensen & Michael R. Horsman. (2020) Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways. Frontiers in Oncology 10.
Crossref
Crossref
Prashant V. Bommi, Vaibhav Chand, Nishit K. Mukhopadhyay, Pradip Raychaudhuri & Srilata Bagchi. (2019) NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC. Oncogene 39:8, pages 1784-1796.
Crossref
Crossref
Adrian L. Harris. 2020. Tumor Vascularization. Tumor Vascularization
147
176
.
Jelena Lukovic, Kathy Han, Melania Pintilie, Naz Chaudary, Richard P. Hill, Anthony Fyles & Michael Milosevic. (2019) Intratumoral heterogeneity and hypoxia gene expression signatures: Is a single biopsy adequate?. Clinical and Translational Radiation Oncology 19, pages 110-115.
Crossref
Crossref
Elham Alsahafi, Katheryn Begg, Ivano Amelio, Nina Raulf, Philippe Lucarelli, Thomas Sauter & Mahvash Tavassoli. (2019) Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death & Disease 10:8.
Crossref
Crossref
Linda Spiegelberg, Ruud Houben, Raymon Niemans, Dirk de Ruysscher, Ala Yaromina, Jan Theys, Christopher P. Guise, Jeffrey B. Smaill, Adam V. Patterson, Philippe Lambin & Ludwig J. Dubois. (2019) Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials. Clinical and Translational Radiation Oncology 15, pages 62-69.
Crossref
Crossref
Brita Singers Sørensen, Christian Nicolaj Andreassen & Jan Alsner. 2019. Radiation Oncology. Radiation Oncology
1
20
.
An-Lun Li, Tao-Sang Chung, Yao-Ning Chan, Chien-Lung Chen, Shih-Chieh Lin, Yun-Ru Chiang, Chen-Huan Lin, Chi-Ching Chen & Nianhan Ma. (2018) microRNA expression pattern as an ancillary prognostic signature for radiotherapy. Journal of Translational Medicine 16:1.
Crossref
Crossref
William A. Hall, Carmen Bergom, Reid F. Thompson, Andrew M. Baschnagel, Srinivasan Vijayakumar, Henning Willers, X. Allen Li, Christopher J. Schultz, George D. Wilson, Catharine M.L. West, Jacek Capala, C. Norman Coleman, Javier F. Torres-Roca, Joanne Weidhaas & Felix Y. Feng. (2018) Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. International Journal of Radiation Oncology*Biology*Physics 101:2, pages 274-284.
Crossref
Crossref
Lingjian Yang & Catharine ML West. (2018) Hypoxia gene expression signatures as predictive biomarkers for personalising radiotherapy. The British Journal of Radiology, pages 20180036.
Crossref
Crossref
Stefan Schmidt, Annett Linge, Alex Zwanenburg, Stefan Leger, Fabian Lohaus, Constanze Krenn, Steffen Appold, Volker Gudziol, Alexander Nowak, Cläre von Neubeck, Inge Tinhofer, Volker Budach, Ali Sak, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Hatice Bunea, Anca-Ligia Grosu, Amir Abdollahi, Jürgen Debus, Ute Ganswindt, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, David Mönnich, Daniel Zips, Gustavo B. Baretton, Frank Buchholz, Michael Baumann, Mechthild Krause & Steffen Löck. (2018) Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy. Clinical Cancer Research 24:6, pages 1364-1374.
Crossref
Crossref
Vincent Grégoire & Jesper Eriksen. (2017) Impact of hypoxia in head and neck cancer radiotherapy. Clinical and Translational Imaging 5:6, pages 497-505.
Crossref
Crossref
Ishna N. Mistry, Matthew Thomas, Ewen D.D. Calder, Stuart J. Conway & Ester M. Hammond. (2017) Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 98:5, pages 1183-1196.
Crossref
Crossref
C. Norman Coleman. (2017) The Radiation Stress Response: Of the People, By the People and For the People. Radiation Research 187:2, pages 129-146.
Crossref
Crossref
Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen, Lise Saksø Mortensen, Kasper Toustrup, Jens Overgaard & Jan Alsner. (2017) Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients. Clinical and Translational Radiation Oncology 2, pages 46-52.
Crossref
Crossref
Corey Speers & Lori J. Pierce. (2017) Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment. International Journal of Breast Cancer 2017, pages 1-7.
Crossref
Crossref
Ninna Aggerholm-Pedersen, Brita Singers Sørensen, Jens Overgaard, Kasper Toustrup, Steen Baerentzen, Ole Steen Nielsen, Katja Maretty-Kongstad, Marianne Nordsmark, Jan Alsner & Akmal Safwat. (2016) A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma. British Journal of Cancer 115:9, pages 1096-1104.
Crossref
Crossref